Cargando…
Integrating Emerging Data Into Clinical Practice: A Case-Based Approach for Multiple Myeloma
Selected Patient Cases From the APSHO Regional Lecture Series INTRODUCTION As the official publication of the Advanced Practitioner Society for Hematology and Oncology (APSHO), JADPRO is pleased to offer Part 2 of an accredited educational activity based on the recently concluded APSHO Regional Lect...
Autor principal: | Kurtin, Sandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Harborside Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6040880/ https://www.ncbi.nlm.nih.gov/pubmed/30018842 |
Ejemplares similares
-
Novel Agents for the Treatment of Multiple Myeloma: Proteasome Inhibitors and Immunomodulatory Agents
por: Kurtin, Sandra E., et al.
Publicado: (2013) -
Refractory IgD Multiple Myeloma Treated with Daratumumab: A Case Report and Literature Review
por: Husnain, Muhammad, et al.
Publicado: (2016) -
Current and emerging immunotherapeutic approaches to the treatment of multiple myeloma
por: Swan, Dawn, et al.
Publicado: (2019) -
Risk Assessment and Risk-Adapted Treatment Selection: A Case-Based Approach for Chronic Lymphocytic Leukemia
por: Kurtin, Sandra, et al.
Publicado: (2017) -
Interpretation of cytogenetic results in multiple myeloma for clinical practice
por: Rajan, A M, et al.
Publicado: (2015)